The median overall survival with niraparib, abiraterone acetate, and prednisone was 30.4 months vs 28.6 months with abiraterone acetate and prednisone alone.
Hannah Clarke
Advertisement
Articles by Hannah Clarke
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Improving Access to Supportive Care on an Organizational Level, With Korie Bigbee
2
Managing Acute and Late Adverse Effects of Breast Cancer Radiation
3
The “Owners” and “Managers” in the Peer-to-Peer Process: What an APP Should Know
4
An NP’s Perspective: Supporting Derm Toxicities in Breast Cancer as a Team
5
